Cargando…
Communication about the Risks and Benefits of Phase I Pediatric Oncology Trials
INTRODUCTION: Phase 1 pediatric oncology trials offer only a small chance of direct benefit and may have significant risks and an impact on quality of life. To date, research has not examined discussions of risks and benefits during informed consent conferences for phase 1 pediatric oncology trials....
Autores principales: | Hazen, Rebecca A., Zyzanski, Stephen, Baker, Justin, Drotar, Dennis, Kodish, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404031/ https://www.ncbi.nlm.nih.gov/pubmed/25638751 http://dx.doi.org/10.1016/j.cct.2015.01.015 |
Ejemplares similares
-
Risk and surrogate benefit for pediatric Phase I trials in oncology: A systematic review with meta-analysis
por: Waligora, Marcin, et al.
Publicado: (2018) -
Further evidence of clinical benefit associated with participation in phase I oncology trials
por: Markman, M
Publicado: (2008) -
Pediatric oncology clinician communication about sexual health with adolescents and young adults: A report from the children’s oncology group
por: Frederick, Natasha N., et al.
Publicado: (2021) -
Details of risk–benefit communication in informed consent documents
for phase I/II trials
por: Kahrass, Hannes, et al.
Publicado: (2020) -
Communication about diagnosis and prognosis—A population‐based survey among bereaved parents in pediatric oncology
por: Bartholdson, Cecilia, et al.
Publicado: (2022)